跳至主要内容
临床试验/CTRI/2024/02/063279
CTRI/2024/02/063279尚未招募4 期

ignocaine Nebulization versus Intravenous Lignocaine to suppress the hemodynamic response to Laryngoscopy and Tracheal Intubation: A Comparative Study - NI

Dr Shipra Chnadra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. patient giving consent
  • 2. all patients aged 18-45yrs
  • 3. ASA grade 1&2
  • 4. both genders
  • 5.hemodynamically stable patients
  • 6. patients undergoing elective surgical procedures under GA
  • 7. patient not receiving any vasoactive drugs.

排除标准

  • 1. Patient refusal for giving consent
  • 2. Patient who already received lignocaine by any route.
  • 3. Hypersensitivity to lignocaine.
  • 4. History of convulsions.
  • 5. Patient receiving vasoactive drug support.
  • 6. Patient on mechanical ventilation with endotracheal or tracheostomy tube.
  • 7. H/O COPD, cardiovascular disease, psychiatric disorders and liver disorders.
  • 8. Patients with anticipated difficult airway.
  • 9. Patients having history of laryngeal, tracheal surgery or any pathology.

研究者

发起方
Dr Shipra Chnadra

相似试验